177 related articles for article (PubMed ID: 26020714)
21. Apraxia of eyelid opening: clinical features and therapy.
Kerty E; Eidal K
Eur J Ophthalmol; 2006; 16(2):204-8. PubMed ID: 16703535
[TBL] [Abstract][Full Text] [Related]
22. Orbicularis oculi muscle graft augmentation after protractor myectomy in blepharospasm.
Yen MT; Anderson RL; Small RG
Ophthalmic Plast Reconstr Surg; 2003 Jul; 19(4):287-96. PubMed ID: 12878877
[TBL] [Abstract][Full Text] [Related]
23. Treatment Effects of Botulinum Toxin Injection and Acupuncture on Blepharospasm Assessed by the Change in Lower Eyelid Tension.
Bao FF; Li QS; Zhang ZY; Xiang MH
Curr Eye Res; 2019 Jun; 44(6):679-683. PubMed ID: 30724635
[No Abstract] [Full Text] [Related]
24. The role of botulinum toxin in correcting frontalis-induced eyelid pseudo-retraction post ptosis surgery.
Shome D; Jain V; Natarajan S
Indian J Ophthalmol; 2007; 55(4):307-8. PubMed ID: 17595485
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
26. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
Sheen-Ophir S; Almog Y
Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
[TBL] [Abstract][Full Text] [Related]
27. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
[TBL] [Abstract][Full Text] [Related]
28. Riolan's muscle: action and indications for botulinum toxin injection.
Mackie IA
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
30. Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection.
Casse G; Adenis JP; Sauvage JP; Robert PY
Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1307-14. PubMed ID: 18581129
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm.
Sung Y; Nam SM; Lew H
Korean J Ophthalmol; 2015 Apr; 29(2):115-20. PubMed ID: 25829828
[TBL] [Abstract][Full Text] [Related]
32. The role of botulinum toxin in correcting frontalis-induced eyelid pseudo-retraction post ptosis surgery.
Dash SK
Indian J Ophthalmol; 2008; 56(1):87-8. PubMed ID: 18158422
[No Abstract] [Full Text] [Related]
33. [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].
Roggenkämper P
Ophthalmologe; 2007 Sep; 104(9):763-6. PubMed ID: 17726608
[TBL] [Abstract][Full Text] [Related]
34. Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial.
Mezaki T; Kaji R; Brin MF; Hirota-Katayama M; Kubori T; Shimizu T; Kimura J
Mov Disord; 1999 Nov; 14(6):1017-20. PubMed ID: 10584680
[TBL] [Abstract][Full Text] [Related]
35. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
36. Disabling muscle of Riolan: A novel concept of orbicularis oculi myectomy for refractory benign essential blepharospasm.
Takahashi Y; Vaidya A; Lee PAL; Kono S; Kakizaki H
Eur J Ophthalmol; 2021 Nov; 31(6):3411-3417. PubMed ID: 33579161
[TBL] [Abstract][Full Text] [Related]
37. Frontalis suspension surgery to treat patients with blepharospasm and eyelid opening apraxia: long-term results.
Dressler D; Karapantzou C; Rohrbach S; Schneider S; Laskawi R
J Neural Transm (Vienna); 2017 Feb; 124(2):253-257. PubMed ID: 27816991
[TBL] [Abstract][Full Text] [Related]
38. Frontalis suspension for essential blepharospasm unresponsive to botulinum toxin therapy. First results.
Roggenkämper P; Nüssgens Z
Ger J Ophthalmol; 1993 Nov; 2(6):426-8. PubMed ID: 8312829
[TBL] [Abstract][Full Text] [Related]
39. The use of botulinum toxin A for treatment of possible essential blepharospasm in a dog.
Meyer-Lindenberg A; Wohlfarth KM; Switzer EN
Aust Vet J; 2003 Oct; 81(10):612-4. PubMed ID: 15080472
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm.
Roggenkämper P; Jost WH; Bihari K; Comes G; Grafe S;
J Neural Transm (Vienna); 2006 Mar; 113(3):303-12. PubMed ID: 15959841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
